The clinical data of patients are presented in Table 1, including osteopenia, osteoporosis status, GD biomarkers (lyso-Gb1, CCL18, and Chito), and inflammatory biomarkers (GM-CSF, TNF-alpha, and CCL2/MCP-1). This evidence concerns the gene GABBR1 and Osteopenia.